The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples